Status:
WITHDRAWN
Progesterone for First Trimester Vaginal Bleeding
Lead Sponsor:
Soroka University Medical Center
Conditions:
Threatened Abortion
Pre-Eclampsia
Eligibility:
FEMALE
16-45 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnan...
Detailed Description
First trimester vaginal bleeding is one of the most common pregnancy complications affecting 15-25% of all pregnancies. Threatened abortion is defined as bleeding through a closed cervical os in the f...
Eligibility Criteria
Inclusion
- Low risk pregnancies
- Intrauterine pregnancy documented sonographically
- Singleton pregnancy
- Known gestational age
- Healthy women
Exclusion
- Women after reproductive assistant techniques
- Women treated with progesterone
- Multiple pregnancies
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01501890
Start Date
January 1 2012
End Date
September 1 2014
Last Update
October 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel